Back to top
more

U.S. Physical Therapy (USPH)

(Delayed Data from NYSE)

$100.38 USD

100.38
62,755

-3.27 (-3.15%)

Updated Apr 25, 2024 04:00 PM ET

After-Market: $100.26 -0.12 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (154 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for USPH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

0 items in cart

U.S. Physical Therapy, Inc. [USPH]

Reports for Purchase

Showing records 1 - 20 ( 20 total )

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 1

11/22/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for USPH 112223

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 2

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for USPH

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 3

09/02/2014

Company Report

Pages: 8

Steady Progress Through First Half. Outlook Remains Very Favorable. Increasing Forecast for 2014 and 2015. Affirm Buy And Increase Price Target From $40 to $42.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 4

05/13/2014

Company Report

Pages: 7

Despite Weather, Q1 Solid. Outlook Remains Very Favorable. Tweaking Forecast For 2014 And Introducing New One For 2015.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 5

03/07/2014

Company Report

Pages: 7

Q4 A Lot Stronger Than It Appeared. Despite Weather, Outlook Remains Very Favorable. Tweaking Forecast.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 6

12/17/2013

Company Report

Pages: 7

Focus on Workers Compensation. Compliments Fit2Work Nicely. Maintain Conviction on USPH Story. Tweaking Forecast. Affirm Buy Rating and $40 PT

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 7

12/11/2013

Company Report

Pages: 7

Fragmented Market. Strong Acquisition and Development Pipeline. Maintain Conviction on USPH Story. Tweaking Forecast.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 8

08/23/2013

Company Report

Pages: 7

Q2 Top Line Beats but EPS Slightly Below Forecast.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 9

05/13/2013

Company Report

Pages: 7

Solid 1Q Report. FY13 Guidance Significantly Above Our Estimates. Increasing Forecasts. Affirm Buy Rating and $30 PT.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 10

03/11/2013

Company Report

Pages: 7

Solid 4Q Report. Storms, Flu Impact Q1, Reducing Forecast; Still Believe Investors Should Buy This Stock

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 11

01/14/2013

Company Report

Pages: 7

Medicare Reimbursement Adjustment Unexpected. Reducing Forecast; Still Believe Investors Should Buy This Stock

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 12

11/12/2012

Company Report

Pages: 7

Solid 3Q Reported. Key Metrics Suggest The Business Is Performing Well. Sandy Impact Obviously

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 13

08/13/2012

Company Report

Pages: 7

USPH: 2Q EPS Misses But Co. Raises Guidance. Buy & $34 PT.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 14

05/25/2012

Company Report

Pages: 7

7 Clinic Acquisition Completed.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 15

05/09/2012

Company Report

Pages: 7

USPH:Strong Q1. Co Regaining Traction. Raise PT To $31. Buy.

Provider: COLLIERS SECURITIES

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 16

03/09/2012

Company Report

Pages: 7

Solid Q4 Results Reported. Company Appears To Be Regaining Traction. Affirm Buy Rating And $25 PT. Continue To Recommend Purchase Of This Industry Leader.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 17

11/18/2011

Company Report

Pages: 7

Follow Up Comments Post Q3. Affirm Buy Rating And $25 PT. Continue To Recommend Purchase Of This Industry Leader

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 18

11/10/2011

Company Report

Pages: 7

3Q Results Impacted By Default By Large OA Franchisee

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 19

08/11/2011

Company Report

Pages: 8

2Q Report In Line With Forecast. 20 Center Acquisition Positive.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 25.00

Research Provided by a Third Party

Company: U.S. Physical Therapy, Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 20

06/20/2011

Company Report

Pages: 13

Initiating Coverage With A Buy Rating And $35 Price Target.

Provider: COLLIERS SECURITIES

Analyst: O'NEIL B

Price: 50.00

Research Provided by a Third Party